[eGongsi Notice] KOSPI - 21st

[Asia Economy Reporter Ji Yeon-jin]

◆ SK Bioscience = Ministry of Food and Drug Safety approved the Phase 3 clinical trial plan (IND) for the COVID-19 vaccine (GBP510) booster shot

◆ NAVER = Regarding rumors of acquiring shares in SM Entertainment (SM), "It has been decided not to consider the investment"

◆ Ssangyong Motor = Submitted an objection regarding delisting of common stock

◆ Kolon Global = Won a construction contract for a small-scale reconstruction project of Hwamak Town in Namcheon-dong, Busan, worth 94.4 billion KRW

◆ TY Holdings = Won a construction contract for new apartment buildings in the Gwangju Central Park - Private Park Development Special Project worth 187.5 billion KRW

◆ Doosan = Subsidiary Doosan Investment decided on a paid-in capital increase worth 229.7 billion KRW

◆ Daeduck = New facility investment worth 270 billion KRW

◆ Samsung Heavy Industries = Acquired equity in a private investment joint venture dedicated to Curious Crete Corporate Financial Stability Institution worth 590 billion KRW

◆ Samsung Electronics = Outside director Han Hwajin voluntarily resigned

◆ Jeju Bank = Q1 sales increased by 19.85% year-on-year to 58.1 billion KRW, operating profit 7.7 billion KRW (-14.79%), net profit 6.1 billion KRW (-21.33%)

This content was produced with the assistance of AI translation services.